🇺🇸 FDA
Pipeline program

Single-Dose Study in Healthy Participants to Compare the Bioavailability of One Film-Coated Mini-Tablet of Indapamide SR 1.5 mg versus One Film-Coated Tablet of Indapamide IR 2.5 mg Under Fasting Conditions, and to Compare the Bioavailability of One Film-Coated Mini-Tablet of Indapamide SR 1.5 mg Under Fasting versus Fed Conditions.

S005183-303

Phase 1 other active

Quick answer

Single-Dose Study in Healthy Participants to Compare the Bioavailability of One Film-Coated Mini-Tablet of Indapamide SR 1.5 mg versus One Film-Coated Tablet of Indapamide IR 2.5 mg Under Fasting Conditions, and to Compare the Bioavailability of One Film-Coated Mini-Tablet of Indapamide SR 1.5 mg Under Fasting versus Fed Conditions. for No medical condition. is a Phase 1 program (other) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
No medical condition.
Phase
Phase 1
Modality
other
Status
active

Clinical trials